Cargando…
Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478023/ https://www.ncbi.nlm.nih.gov/pubmed/37675089 http://dx.doi.org/10.21037/cdt-2023-5 |
| _version_ | 1785101258358521856 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10478023 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104780232023-09-06 Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials Cardiovasc Diagn Ther Retraction AME Publishing Company 2023-07-25 2023-08-31 /pmc/articles/PMC10478023/ /pubmed/37675089 http://dx.doi.org/10.21037/cdt-2023-5 Text en 2023 Cardiovascular Diagnosis and Therapy. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Retraction Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title | Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title_full | Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title_fullStr | Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title_full_unstemmed | Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title_short | Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| title_sort | retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478023/ https://www.ncbi.nlm.nih.gov/pubmed/37675089 http://dx.doi.org/10.21037/cdt-2023-5 |
| work_keys_str_mv | AT retractiondifferentialefficacyprofileofaldosteronereceptorantagonistsdependingonthetypeofchronicheartfailurewhetherwithreducedorpreservedleftventricularejectionfractionresultsofametaanalysisofrandomizedcontrolledtrials |